Priority Date: 19.09.12 (US 201261702765P)

2-OXO-2,3,4,5-TETRAHYDRO-1 H-BENZO[B]DIAZEPINES AND THEIR USE IN THE TREATMENT OF CANCER

  • Application ID: EP13766920
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 191 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 19.09.2012 - Priority Date (US 201261702765P)
  • 27.03.2014 - Publication A1 (WO2014044622)
  • 29.07.2015 - Publication A1 (EP2897972)
  • 30.11.2016 - Publication B1 (EP2897972)

IPC Classification